[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CRDL":3,"homepage-market-summary":30,"stock-news-CRDL":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"CRDL","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"Cardiol Therapeutics Inc. Class A Common Shares","Nasdaq",null,"Common Stock","Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.","18",false,{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},1.41,1.6,1.64,1.4,1.56,-0.15,-9.62,3580248.73621,6267,1.4821,2.34,0.88,730178.537636288,36.3,1938,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":13,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":13},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},9,[175,181,187,193,198,204,210,216,222],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"Fund manager reports 6.4M Cardiol Therapeutics (NASDAQ: CRDL) shares - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxNUmlUeng3Mmt5b0l3cFdaamo2c04yQ2s3MHBiamJ6dmM5d0FlVnZudGxzLVRNUDBNazVqSjVmZGZjTTFzc1k0UW9KRGlUWXoyaTRBUGJfVXFKckFnazhiM3QyRXFjTy02R2NBbmk1bkZGNDhkSlRhSWlWVFJkRW1NdU9XV3dZeWNhU3NCR2NTYkNjNlZVdXBGbW42UzllNGRIRWd0NVVjeTdPUFRtOFpvMVlXSHJwT3BwTVNNSFBPN3E4dWdTRnJSSzRMYw?oc=5","Wed, 23 Sep 2026 16:17:02 GMT","Fund manager reports 6.4M Cardiol Therapeutics (NASDAQ: CRDL) shares Stock Titan","Stock Titan",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxQMzRJR2JEU2lJZWVMc3N0c3h4N3ZmdVlxNEQ3LW95aW5SVVNhRWVkbWhTdGJ1NV9WWDdrNmxieXp6ZHZYOUNJN25BMjYyTGhlUURYdmZIMnFjcVFEMEpoNkdqMk5VQk9QZHI3VzhCY2JacjRyMzQ3UmVFcFBGWi1vYW1sQldNMERHb0h0LTRFdUJwcFpUZG5CSWwyWHJOa2dMekc2NTdTeDVUQQ?oc=5","Thu, 01 Oct 2026 18:39:34 GMT","Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year? Yahoo Finance","Yahoo Finance",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sat, 03 Oct 2026 12:14:18 GMT","Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation Simply Wall Street","Simply Wall Street",{"title":194,"link":195,"pubDate":196,"description":197,"source":180},"Fewer relapses in heart trial push Cardiol Therapeutics (CRDL) to add patients and delay results - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxNZk1OWnB0c0NzOTI1S1RDVWVtVFcyV05NWHFsdFlTaG1VdFlWa2hMYXRkSjY3Y3ZueWRmLWd5ckJWMlJaMUpUM2JPMVdKaUJEVUZna0RES3Rqek9WNTgyVjM2OG0xMElaVU5yaXdjaWJMOElZeFpmMkNRajUwS0RxclFvZGRyUlpPYXdMamVHUDFWd3pzaTNUazFGUG5PVTIwdVlXZzlCdnB4U1g3VjRuOGFBdGZMdVRvWXUtaQ?oc=5","Wed, 23 Sep 2026 10:38:49 GMT","Fewer relapses in heart trial push Cardiol Therapeutics (CRDL) to add patients and delay results Stock Titan",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"Cardiol Therapeutics Inc. Class A (TSX:CRDL) Slides -5.91% as Investors Reassess Near-Term Catalysts and Risk - kalkine.ca","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0wFBVV95cUxQcGF3WDctRDQ1bk9lN2x3YXRZZE9ubjB6TEM2QVF4RXY5T05NV09VTkpwMVVhSzhCcHdtdmF5a3RVM3VQeXp4SS02NDlnYUFNZnp6TEFhdnl3ZkZYbEZpTGlLd29CRXZpWXN0akwzS3pOWjlaSW5IYUhXVG5vVGVkX0czeUlmSjZ2WFRSd01oWDQyWURZYkN5V0J5b1hEMm02UENiaDB4TlE0YmZlOXA5NzN6TUpOVmhCbVgzN2Z1WnhzZ0ZqNDlCelFneVphaWNFT2Vn?oc=5","Fri, 02 Oct 2026 11:11:00 GMT","Cardiol Therapeutics Inc. Class A (TSX:CRDL) Slides -5.91% as Investors Reassess Near-Term Catalysts and Risk kalkine.ca","kalkine.ca",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"HC Wainwright & Co. reiterates Buy rating on Cardiol Therapeutics, $9 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxPdF92VUluaG1SNWtjTUNGTUxKQ2lqUFhmT3Q2ODZoVjdidnZhbTM1LXQ1OUlESmJBUjlRazdudUV3N3B1a21JWTJacnZpN01Jd214cV9aNVBfY1BpNXlCeWxXMXN5RVFfVjB4bTRFcmdfc29EU05kM2NTMDhCZ0dqN2JRYjd2RDB6Zkpib2hTOWFvdFAtU0dfUXNERUo3WkZBRS1vVkxBZGZzeHFlNHpNdGdFOUczd09WVnllbnluaml1eVpNNnlSWXBOS1RHSHRtRm02cldB?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","HC Wainwright & Co. reiterates Buy rating on Cardiol Therapeutics, $9 price target TradingView","TradingView",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"Tejara Capital Holds 5.3% Stake in Cardiol Therapeutics (NASDAQ: CRDL), Owning 6.38 Million Shares - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1AFBVV95cUxNajA4WWNabTVNU2RELTVtbFRhQktvV2lYVGNTRUVHT0VraFdyMU1wZUFOWWVpcXVHd1lsci1xNjJoTVNUbktHS0thNHVncXB2Sl9Gbk9JSy0zMzRYWEgyWERHU1dUdGhzVkZvNnJMVzRCWWVMa1hZYXVjRkY2ZUhiSlh2Z0NRSTVwUEo3ek5PR2lseS1GTUtvRS1TRS1wN1p0c1dtV0hHTGRDOFlBZTFCcHI1LWZndF9zLVNOMGo5T281ZzZuRk54V2s4b0h3WFQ4UEhKZg?oc=5","Wed, 23 Sep 2026 19:12:00 GMT","Tejara Capital Holds 5.3% Stake in Cardiol Therapeutics (NASDAQ: CRDL), Owning 6.38 Million Shares Kalkine Media","Kalkine Media",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"CRDL Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares as Clinical-Stage Story Holds - Annual Financial Report - siam.in","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxOQXJ6aFhSNGRaUk94WmFKU2dtWXQtbnl6M3BiRk5ZT1pzMHljY1FySEdCYUdENGlLWjhmc3o0SjFIYmxYbTB3bkpQY3h2Wkd2QWVSekFsaTJERjdyUldkRkVINkRqUkYyOWFkNk9Ya18xcnI4aTJOQ0N4NFB3bFB0WHRRb09WNWN2WWdTUzZQZGFHTjZmaHZ5ZmlBRnp1eHd3UVoteGtDU0Z4TVJqUTBIaHh4V3M3RzFFMTd0RjRCNGFTTEszMXh6LVdyMA?oc=5","Sun, 20 Sep 2026 19:31:02 GMT","CRDL Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares as Clinical-Stage Story Holds - Annual Financial Report siam.in","siam.in",{"title":223,"link":224,"pubDate":225,"description":226,"source":215},"Can Cardiol Therapeutics (TSX:CRDL) Turn Research Into Progress? - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxNd1QzRE1JbkZ6cGg5M3lwQWxSNTB2QUtQNzAzMHVwUllUbGpjUVNwRjBUMWdJdlRURms3ZUI3X01Oa2FRUmFrV2w3eXNVLUIzMk1nMEVySGtQTkotSzRETTZqTmlXUEs5T2dleXpvb3ZDWjBxMHRlSkpyc1YtaHZoajFLaUVVcVZJUnUwM1NWY25LaU4tNUcxa3NVMGZSVEJNZlZ6UnVXUzZEUQ?oc=5","Mon, 28 Sep 2026 21:16:00 GMT","Can Cardiol Therapeutics (TSX:CRDL) Turn Research Into Progress? Kalkine Media"]